Sector revisions Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-22 EDT			5-day change	1st Jan Change
18.67 ^USD	+1.97%		+3.04%	+19.07%

05-07	Monte Rosa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-07	Earnings Flash (GLUE) Monte Rosa Therapeutics, Inc. Reports Q1 Revenue $4.2M, vs. FactSet Est of $11.4M	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Nbr of analysts
MONTE ROSA THERAPEUTICS, INC.			6
LONZA GROUP AG			23
REVOLUTION MEDICINES, INC.			21
BEONE MEDICINES AG			27
IQVIA HOLDINGS INC.			19
CELLTRION, INC.			24
ASCENDIS PHARMA A/S	-	-	18
MEDPACE HOLDINGS, INC.			12
EUROFINS SCIENTIFIC SE			14
IONIS PHARMACEUTICALS, INC.			23
ICON PUBLIC LIMITED COMPANY			16
TEMPUS AI, INC.			15
BIO-TECHNE CORPORATION			13
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.			15
PRAXIS PRECISION MEDICINES, INC.			18
ABIVAX			7
QIAGEN N.V.			14
ALKERMES PLC			16
KYMERA THERAPEUTICS, INC.			21
PROTAGONIST THERAPEUTICS, INC.			13
Average			17
Weighted average by Cap.			19

×